McRae Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6M | Buy |
30,453
+125
| +0.4% | +$55.7K | 2.78% | 16 |
|
|
2025
Q1 | $14.7M | Sell |
30,328
-750
| -2% | -$364K | 3.1% | 12 |
|
|
2024
Q4 | $12.5M | Sell |
31,078
-802
| -3% | -$323K | 2.45% | 19 |
|
|
2024
Q3 | $14.8M | Sell |
31,880
-1,640
| -5% | -$763K | 2.89% | 15 |
|
|
2024
Q2 | $15.7M | Sell |
33,520
-420
| -1% | -$197K | 3.58% | 11 |
|
|
2024
Q1 | $14.2M | Sell |
33,940
-785
| -2% | -$328K | 3.11% | 15 |
|
|
2023
Q4 | $14.1M | Sell |
34,725
-543
| -2% | -$221K | 3.53% | 12 |
|
|
2023
Q3 | $12.3M | Sell |
35,268
-312
| -0.9% | -$108K | 3.63% | 11 |
|
|
2023
Q2 | $12.5M | Buy |
35,580
+231
| +0.7% | +$81.3K | 3.56% | 12 |
|
|
2023
Q1 | $11.1M | Sell |
35,349
-410
| -1% | -$129K | 3.21% | 14 |
|
|
2022
Q4 | $10.3M | Sell |
35,759
-606
| -2% | -$175K | 3.02% | 14 |
|
|
2022
Q3 | $10.5M | Sell |
36,365
-130
| -0.4% | -$37.6K | 3.2% | 13 |
|
|
2022
Q2 | $10.3M | Buy |
36,495
+7,995
| +28% | +$2.25M | 2.79% | 15 |
|
|
2022
Q1 | $7.44M | Buy |
+28,500
| New | +$7.44M | 1.68% | 26 |
|